Notizie

BEIJING, AUGUST 24, 2021 - Lepu Medical Technology (Beijing) Co., Ltd. (“Lepu Medical”), a leading global company specialized in developing, manufacturing and marketing high-tech medical devices and equipment, today announced that its Siringa sterile per la linea monouso Ha ottenuto l'approvazione del marchio CE per uso generale, inclusa la consegna di vari vaccini COVID-19.

Il marchio CE indica che la siringa sterile per monouso di Lepu Medical soddisfa gli standard di categoria dell'Unione europea (UE) per la sicurezza e le prestazioni per l'uso da parte degli operatori sanitari per l'aspirazione e l'iniezione di fluidi per uso generale, che li rende disponibili per l'acquisto professionale in tutta l'UE e in altri paesi che riconoscono il marchio CE.

Lepu Medical’s Siringa sterile per la linea monouso has received CE Mark approval at a time of high-demand for needles suitable to vaccinate populations against the COVID-19 pandemic.  Lepu Medical’s syringe series offers a variety of single-use needles for many applications, including various COVID-19 vaccines. The line includes both Luer Lock and Lock Slip syringes, a clear barrel, plunger, plunger stopper, needle, and cap. Lepu Medical’s syringe series offers a higher resistance to breakage in single-use, and latex-free pistons. The total graduated capacity of all models of syringes is 1mL, with a range of needle sizes to meet a variety of injection and COVID-19 vaccine needs, each distinguished by the color of the needle hub.

Designed to meet a variety of injection needs, Lepu Medical’s Sterile Syringe For Single-Use brings improved safety to patients and doctors with its clear barrel for convenient control of foreign substances. The Sterile Syringe For Single-Use is intended only for one-time use by  healthcare professionals who have received training on medical injection techniques. Injection and vaccine administrators can refer to the Lepu Medical professional manual before use for a full understanding of the device instructions, warnings and precautions.

Oltre alla siringa sterile per monouso, Lepu Medical ha fornito varie forniture mediche per la prevenzione e il controllo dei COVID-19, tra cui il kit di test rapido dell'antigene SARS-CoV-2 per l'autotest e il kit di test degli anticorpi SARS-CoV-2 per i test degli operatori sanitari. Lepu Medical offre anche soluzioni diagnostiche COVID-19 come prodotti e soluzioni di acido nucleico per fornire test standard per la diagnosi di COVID-19 e prodotti per test di anticorpi per monitorare i livelli di immunità COVID-19. Gli altri prodotti e soluzioni COVID-19 di Lepu Medical includono kit di raccolta campioni, kit di estrazione manuale dei campioni, estrattori automatici di campioni e sistemi PCR in tempo reale per la diagnostica clinica standard degli acidi nucleici.

As of August 2021, the number of global daily doses of COVID-19 vaccines continues to rise, driving demand for vaccines and vaccination supplies. According to published statistics, by the end of 2020, major governments had placed purchases for over nine billion vaccine units. With the onset of the Delta virus, vaccination rates are ramping up and the expected number of vaccine units is increasing. Government officials and medical professionals across the globe from Israel, France, Germany, the U.S, the United Arab Emirates, Bahrain, the United Kingdom, Switzerland, Cambodia and others are proposing and actively preparing for the third dose of the COVID-19 vaccination to strengthen pandemic prevention and control efforts. With the CE Mark approval for the Sterile Syringe For Single-Use, Lepu Medical will continue to proactively seek qualified partners to support the availability of reliable vaccine supplies across the globe, and assist with COVID-19 management and continuation of general medical practices.